MOTS-c
Mitochondrial-derived peptide MOTS-c activates metabolic signaling but blunts reparative function in human mesenchymal stromal cells
Journal: Inflammation and Regeneration. Publication date: 22 June 2026. PMID: 42324588. DOI: 10.1186/s41232-026-00431-7. This paper examines metabolic signalling and reparative function in human mesenchymal stromal cells.
Limitations and interpretation
Cell-based experimental findings are not proof of a clinical effect in people receiving MOTS-c.
Open original source / literature record ↗